TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,538 | -1.5% | 2,039 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $32,028 | -4.7% | 2,039 | 0.0% | 0.01% | -8.3% |
| Q1 2023 | $33,598 | +104893.8% | 2,039 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $32 | -99.8% | 2,039 | +28.9% | 0.01% | +33.3% |
| Q3 2022 | $21,000 | -4.5% | 1,582 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $22,000 | -18.5% | 1,582 | -15.9% | 0.01% | 0.0% |
| Q1 2022 | $27,000 | +3.8% | 1,882 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $26,000 | -40.9% | 1,882 | -29.4% | 0.01% | -50.0% |
| Q3 2021 | $44,000 | -4.3% | 2,667 | -2.5% | 0.02% | -14.3% |
| Q2 2021 | $46,000 | 0.0% | 2,736 | +8.3% | 0.02% | -4.5% |
| Q1 2021 | $46,000 | +170.6% | 2,527 | +172.9% | 0.02% | +120.0% |
| Q4 2020 | $17,000 | 0.0% | 926 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $17,000 | 0.0% | 926 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $17,000 | +21.4% | 926 | 0.0% | 0.01% | +8.3% |
| Q1 2020 | $14,000 | -39.1% | 926 | -19.2% | 0.01% | -25.0% |
| Q4 2019 | $23,000 | +15.0% | 1,146 | 0.0% | 0.02% | +45.5% |
| Q3 2019 | $20,000 | 0.0% | 1,146 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $20,000 | -13.0% | 1,146 | 0.0% | 0.01% | -15.4% |
| Q1 2019 | $23,000 | – | 1,146 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |